Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vobarilizumab (ALX-0061) is a monoclonal antibody (mAb) targeting the IL-6 receptor (IL-6R) with a dissociation constant (Kd) of 0.19 pM, indicating high affinity for its target. This compound features both an anti-IL-6R domain and an anti-human serum albumin domain, making it a potential research tool for investigating inflammatory autoimmune diseases like rheumatoid arthritis [1] [2] [3].
説明 | Vobarilizumab (ALX-0061) is a monoclonal antibody (mAb) targeting the IL-6 receptor (IL-6R) with a dissociation constant (Kd) of 0.19 pM, indicating high affinity for its target. This compound features both an anti-IL-6R domain and an anti-human serum albumin domain, making it a potential research tool for investigating inflammatory autoimmune diseases like rheumatoid arthritis [1] [2] [3]. |
分子量 | N/A |
CAS No. | 1628814-88-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vobarilizumab 1628814-88-9 Inhibitor inhibitor inhibit